세계의 방사선 종양학 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Radiation Oncology Market size is anticipated to grow from USD 9.58 Billion in 2024 to USD 17.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.23% during the forecast period of 2026 to 2033.

The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.

Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.

Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• Systemic Radiation Therapy

By Application

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Others

By End-User

• Hospitals
• Ambulatory Radiotherapy Centers
• Cancer Research Institutes
• Others
• COMPANIES PROFILED
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Varian Medical Systems
• Elekta
• Hitachi Medical Corporation
• IBA Worldwide
• Accuray Incorporated
• Advanced Accelerator Applications
• Nordion Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. RADIATION ONCOLOGY a€" INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. External Beam Radiation Therapy Historic and Forecast Sales By Regions
• 5.4. Internal Beam Radiation Therapy Historic and Forecast Sales By Regions
• 5.5. Systemic Radiation Therapy Historic and Forecast Sales By Regions

6. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Breast Cancer Historic and Forecast Sales By Regions
• 6.4. Lung Cancer Historic and Forecast Sales By Regions
• 6.5. Prostate Cancer Historic and Forecast Sales By Regions
• 6.6. Colorectal Cancer Historic and Forecast Sales By Regions
• 6.7. Head and Neck Cancer Historic and Forecast Sales By Regions
• 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-User
• 7.2. Historical and Forecast Data Analysis By End-User
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Ambulatory Radiotherapy Centers Historic and Forecast Sales By Regions
• 7.5. Cancer Research Institutes Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
    
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIATION ONCOLOGY COMPANIES

• 9.1. Radiation Oncology Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF RADIATION ONCOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Siemens Healthineers
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. GE Healthcare
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Philips Healthcare
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Varian Medical Systems
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Elekta
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Hitachi Medical Corporation
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. IBA Worldwide
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Accuray Incorporated
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Advanced Accelerator Applications
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Nordion Inc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies